News

Four Keys To Successfully Launching AI In Life Sciences
AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and ...
Morningstar21d
Emmaus Life Sciences Receives FDA Approval for Endari® Label ...
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, marketing, and sale of innovative treatments and therapies, including those for ...
Yahoo Finance4mon
Greenwich LifeSciences Provides Update on Open Label Safety Data from ...
STAFFORD, Texas, March 17, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial ...
Morningstar3mon
Anavex Life Sciences Announces Positive up to 4-Years ... - Morningstar
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease ...
Yahoo Finance21d
Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements
Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that it has received Food and Drug Administration (FDA) approval for changes to the labelling ...
WGN Radio21d
Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements
Changes Based on Additional Pharmacokinetics Data TORRANCE, Calif., June 26, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today ...